Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Completed · Phase 2

Conditions studied: Atopic Dermatitis, Pruritus

In brief

The purpose of this study is to find out if investigational device, RD047-26, is safe and useful for the treatment of mild to moderate atopic dermatitis.

Key facts

Study ID

NCT01232985

Run by

Oculus Innovative Sciences, Inc.

People needed

17

Starts

2010-10-01

Expected to finish

2010-12-01

Last updated by the study team

2012-05-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent
• Female or male, 18 to 65 years of age and in good general health
• Clinical diagnosis of stable mild to moderate atopic dermatitis
• Willing and able to follow study instructions and likely to complete all study requirements

You may not qualify if…

• Severe or uncontrolled asthma
• Pregnant, nursing, or planning a pregnancy during the study; or is a WOCBP but is not willing to use an effective method of birth control
• Current enrollment in an investigational drug or device study or participation in such a study within the last 30 days prior to Baseline (Day 0)

Where it is running

• Dermatology Consulting Services — High Point, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.